| Literature DB >> 34414916 |
Rubleen Kaur1, Diksha Jassal1, Naveenta Sharma1, Kamaljeet Kaur1, Sukhjot Kaur1, Manjula Thakur1, Sushma K Saini1, Madhu Gupta1, Anjali Sharma1.
Abstract
Entities:
Mesh:
Year: 2021 PMID: 34414916 PMCID: PMC8411957 DOI: 10.4103/ijp.IJP_486_18
Source DB: PubMed Journal: Indian J Pharmacol ISSN: 0253-7613 Impact factor: 1.200
Knowledge and practice of women regarding vaccination of under-5 children (n=173)
| Age and vaccine | Knowledge of mother regarding vaccine | Number of eligible children for vaccination | Timely given, | Late given, |
|---|---|---|---|---|
| Birth | ||||
| BCG | 67 (41.2) | 173 | 173 (100) | - |
| OPV | 120 (75.7) | 173 | 173 (100) | - |
| Hepatitis B | 31 (19.1) | 173 | 173 (100) | - |
| 6 weeks | ||||
| OPV-1 | 120 (75.7) | 171 | 171 (100) | - |
| DPT-1, hepatitis B-1/penta-1 | 5 (3.10) | 171 | 171 (100) | - |
| IPV-1 | 30 (18.4) | 171 | 171 (100) | - |
| Rota vaccine* | 1 (0.60) | 171 | 1 (0.6) | - |
| 10 weeks | ||||
| OPV-2 | 120 (75.7) | 169 | 167 (98.8) | 2 (1.2) |
| DPT 2, hepatitis B 2/penta-2 | 5 (3.10) | 169 | 167 (98.8) | 2 (1.2) |
| Rota vaccine* | 1 (0.60) | 169 | 1 (0.5) | - |
| 14 weeks | ||||
| OPV-3 | 120 (75.7) | 169 | 169 (100) | - |
| DPT 3, hepatitis B-3/penta-3 | 5 (3.10) | 169 | 169 (100) | - |
| IPV 2 | 30 (18.4) | 169 | 169 (100) | - |
| Rota vaccine* | 1 (0.60) | 169 | 1 (0.5) | - |
| 9 months | - | |||
| Vitamin-A1 | 120 (75.7) | 159 | 159 (100) | - |
| Measles/MR | 30 (18.4) | 159 | 159 (100) | - |
| 16-24 months | ||||
| DPT booster-1 | 5 (3.10) | 137 | 136 (99.2) | - |
| OPV booster | 120 (75.7) | 137 | 136 (99.2) | 1 (0.8) |
| Measles 2/MR-2 | 30 (18.4) | 137 | 136 (99.2) | 1 (0.8) |
| Vitamin A-2 (second-ninth dose) | 120 (75.7) | 137 | 136 (99.2) | 1 (0.8) |
| 5-6 years | ||||
| DPT booster-2 | 5 (3.10) | 137 | 137 (100) | 1 (0.8) |
*Purchased. BCG=Bacillus Calmette Guerin, OPV=Oral polio vaccine, DPT=Diphtheria, pertussis and tetanus, IPV=Inactivated poliovirus vaccine, MR=Measles and rubella